COVID-19:東ソー、抗体検査試薬開発へ:横浜市大、関東化学と連携(動画):  COVID-19: Tosoh to develop antibody test reagents: Yokohama City Univ, with Kanto Kagaku:  COVID-19:Tosoh开发抗体测试试剂:横滨市立大学,与关东化学(Kanto Kagaku)合作

flu, Drugs, Pharmaceutical

COVID-19:Schiffmann’s coronavirus tracker:1日に3000万人が訪問(動画):  High school student Avi Schiffmann made a coronavirus tracker:  高中生Avi Schiffmann制作了冠状病毒追踪仪

flu, 4 IT, Solution

COVID-19:東大、アビガン中間体/高効率合成法:収率ほぼ100%(動画):  COVID-19: Univ of Tokyo, Avgigan intermediate/highly efficient synthetic method: Yield almost 100%:  COVID-19:东京大学Avgigan中/高效合成方法:收率接近100%

flu, Drugs, Statistics, Pharmaceutical

COVID-19:フィリピン保健省、アビガン治験を開始へ:Around 80 to 100 patients:  DOH allots P18-M for trials of flu drug Avigan as COVID-19 treatment:  DOH分配P18-M用于流感药物Avigan作为COVID-19治疗的试验

flu, Drugs, Pharmaceutical

COVID-19:RDIF/ChemRar、アビガン(ファビピラビル)治験良好:有効性80%以上:  RDIF and ChemRar Launch Final Stage of Favipiravir Clinical Trial:  RDIF和ChemRar启动Favipiravir临床试验的最终阶段-

flu, Drugs, Pharmaceutical

Posts navigation